Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737

Leukemia and Lymphoma

Volumn 52, Issue SUPPL. 2, 2011, Pages 79-81

  Fitzgerald, David J ^a   Moskatel, Elizabeth ^a   Ben Josef, Gal ^a   Traini, Roberta ^a   Tendler, Tara ^a   Sharma, Ashima ^a   Antignani, Antonella ^a   Mussai, Francis ^a   Wayne, Alan ^a   Kreitman, Robert J ^a   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ABT 737; apoptosis; BH3 only; Pseudomonas exotoxin

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CASPASE 3; IMMUNOTOXIN; IMMUNOTOXIN BH3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR CELL;

ANTIGENS, CD22; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIPHENYL COMPOUNDS; DRUG SYNERGISM; HUMANS; IMMUNOTOXINS; LEUKEMIA, HAIRY CELL; NITROPHENOLS; PIPERAZINES; SULFONAMIDES;

EID: 79957484300     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.569961     Document Type: Article

References (7)

1. Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ. Immunotoxin treatment of cancer. Annu Rev Med 2007;58:221-237. (Pubitemid 46706511)
2. Du X, Youle RJ, FitzGerald DJ, Pastan I. Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1. Mol Cell Biol 2010;30: 3444-3452.
3. Andersson Y, Juell S, Fodstad Ø. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. Int J Cancer 2004;112:475-483. (Pubitemid 39390614)
4. Onda M, Beers R, Xiang L, Nagata S, Wang QC, Pastan I. An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proc Natl Acad Sci USA 2008;105:11311-13116.
5. Zhang Y, Xiang L, Hassan R, Pastan I. Immunotoxin and taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors. Proc Natl Acad Sci USA 2007;104:17099-17104. (Pubitemid 350210998)
6. Traini R, Ben-Josef G, Pastrana DV, et al. ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol. Mol Cancer Ther 2010;9:2007- 2015.
7. Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005;435:677-681. (Pubitemid 40825512)